Tchuenkam P, Ngum L, Ali I, Chedjou J, Nji A, Netongo P
Wellcome Open Res. 2024; 9:323.
PMID: 39649624
PMC: 11624434.
DOI: 10.12688/wellcomeopenres.22347.1.
Nguyen G, Cooper C, McWhorter O, Sharma R, Elliot A, Ruberto A
Malar J. 2024; 23(1):357.
PMID: 39580415
PMC: 11585928.
DOI: 10.1186/s12936-024-05155-y.
Srisutham S, Madmanee W, Kouhathong J, Sutawong K, Tripura R, Peto T
PLoS One. 2022; 17(12):e0278928.
PMID: 36525403
PMC: 9757559.
DOI: 10.1371/journal.pone.0278928.
Kuesap J, Suphakhonchuwong N, Kalawong L, Khumchum N
Korean J Parasitol. 2022; 60(2):109-116.
PMID: 35500892
PMC: 9058275.
DOI: 10.3347/kjp.2022.60.2.109.
Imwong M, Suwannasin K, Srisutham S, Vongpromek R, Promnarate C, Saejeng A
Antimicrob Agents Chemother. 2021; 65(12):e0112121.
PMID: 34516247
PMC: 8597770.
DOI: 10.1128/AAC.01121-21.
Decreased Susceptibility to Dihydrofolate Reductase Inhibitors Associated With Genetic Polymorphisms in Ugandan Plasmodium falciparum Isolates.
Kreutzfeld O, Tumwebaze P, Byaruhanga O, Katairo T, Okitwi M, Orena S
J Infect Dis. 2021; 225(4):696-704.
PMID: 34460932
PMC: 8844592.
DOI: 10.1093/infdis/jiab435.
High multiple mutations of Plasmodium falciparum-resistant genotypes to sulphadoxine-pyrimethamine in Lagos, Nigeria.
Quan H, Igbasi U, Oyibo W, Omilabu S, Chen S, Shen H
Infect Dis Poverty. 2020; 9(1):91.
PMID: 32653033
PMC: 7353807.
DOI: 10.1186/s40249-020-00712-4.
Molecular characterization of Plasmodium falciparum antifolate resistance markers in Thailand between 2008 and 2016.
Sugaram R, Suwannasin K, Kunasol C, Mathema V, Day N, Sudathip P
Malar J. 2020; 19(1):107.
PMID: 32127009
PMC: 7055081.
DOI: 10.1186/s12936-020-03176-x.
Understanding the Pyrimethamine Drug Resistance Mechanism via Combined Molecular Dynamics and Dynamic Residue Network Analysis.
Amusengeri A, Tata R, Tastan Bishop O
Molecules. 2020; 25(4).
PMID: 32085470
PMC: 7070769.
DOI: 10.3390/molecules25040904.
In vitro selection predicts malaria parasite resistance to dihydroorotate dehydrogenase inhibitors in a mouse infection model.
Mandt R, Lafuente-Monasterio M, Sakata-Kato T, Luth M, Segura D, Pablos-Tanarro A
Sci Transl Med. 2019; 11(521).
PMID: 31801884
PMC: 7444640.
DOI: 10.1126/scitranslmed.aav1636.
The relative rate of kill of the MMV Malaria Box compounds provides links to the mode of antimalarial action and highlights scaffolds of medicinal chemistry interest.
Ullah I, Sharma R, Mete A, Biagini G, Wetzel D, Horrocks P
J Antimicrob Chemother. 2019; 75(2):362-370.
PMID: 31665424
PMC: 8204706.
DOI: 10.1093/jac/dkz443.
The genomic architecture of antimalarial drug resistance.
Cowell A, Winzeler E
Brief Funct Genomics. 2019; 18(5):314-328.
PMID: 31119263
PMC: 6859814.
DOI: 10.1093/bfgp/elz008.
The prevalence and antifolate drug resistance profiles of Plasmodium falciparum in study participants randomized to discontinue or continue cotrimoxazole prophylaxis.
Juma D, Muiruri P, Yuhas K, John-Stewart G, Ottichilo R, Waitumbi J
PLoS Negl Trop Dis. 2019; 13(3):e0007223.
PMID: 30897090
PMC: 6445470.
DOI: 10.1371/journal.pntd.0007223.
High resolution melting: a useful field-deployable method to measure dhfr and dhps drug resistance in both highly and lowly endemic Plasmodium populations.
Ndiaye Y, Diedhiou C, Bei A, Dieye B, Mbaye A, Papa Mze N
Malar J. 2017; 16(1):153.
PMID: 28420422
PMC: 5395743.
DOI: 10.1186/s12936-017-1811-2.
Unexpected selections of Plasmodium falciparum polymorphisms in previously treatment-naïve areas after monthly presumptive administration of three different anti-malarial drugs in Liberia 1976-78.
Jovel I, Bjorkman A, Roper C, Martensson A, Ursing J
Malar J. 2017; 16(1):113.
PMID: 28288632
PMC: 5347173.
DOI: 10.1186/s12936-017-1747-6.
Metabolomic Profiling of the Malaria Box Reveals Antimalarial Target Pathways.
Allman E, Painter H, Samra J, Carrasquilla M, Llinas M
Antimicrob Agents Chemother. 2016; 60(11):6635-6649.
PMID: 27572391
PMC: 5075069.
DOI: 10.1128/AAC.01224-16.
Low-grade sulfadoxine-pyrimethamine resistance in Plasmodium falciparum parasites from Lubango, Angola.
Kaingona-Daniel E, Gomes L, Gama B, Almeida-de-Oliveira N, Fortes F, Menard D
Malar J. 2016; 15:309.
PMID: 27267365
PMC: 4895897.
DOI: 10.1186/s12936-016-1358-7.
Antimalarial drug resistance in Africa: key lessons for the future.
Takala-Harrison S, Laufer M
Ann N Y Acad Sci. 2015; 1342:62-7.
PMID: 25891142
PMC: 4527866.
DOI: 10.1111/nyas.12766.
Genetic mutations in Plasmodium falciparum and Plasmodium vivax dihydrofolate reductase (DHFR) and dihydropteroate synthase (DHPS) in Vanuatu and Solomon Islands prior to the introduction of artemisinin combination therapy.
Gresty K, Gray K, Bobogare A, Wini L, Taleo G, Hii J
Malar J. 2014; 13:402.
PMID: 25311473
PMC: 4203929.
DOI: 10.1186/1475-2875-13-402.
Molecular analysis of chloroquine and sulfadoxine-pyrimethamine resistance-associated alleles in Plasmodium falciparum isolates from Nicaragua.
Sridaran S, Rodriguez B, Soto A, de Oliveira A, Udhayakumar V
Am J Trop Med Hyg. 2014; 90(5):840-5.
PMID: 24615126
PMC: 4015575.
DOI: 10.4269/ajtmh.13-0214.
